Abstract 15613: Re-Analysis of Landmark Statin Trials in Heart Failure Patients Using Competing Risks Methods — Matthew J. Feinstein (2013) | RDL Network
Abstract 15613: Re-Analysis of Landmark Statin Trials in Heart Failure Patients Using Competing Risks Methods
Article 2013 en
Authors
MF
Matthew J. Feinstein
PJ
Pardeep S. Jhund
JK
Joseph Kang
Abstract
1 min read
Introduction: To date, no large randomized trials of heart failure (HF) patients have demonstrated significant reductions in atherothrombotic cardiovascular (CV) events with statin use. Substantial...
Akshay S. Desai, Henry Krum, Changhong Yu, Scott M. Wasserman, Eduard Apetrei, Vijay Chopra, Mareev VIu, Aldo Maggioni, John J.V. McMurray, Marc A. Pfeffer, Karl Swedberg, James B. Young
Daniel Pham, Mingming Yang, Arzu Kalaycı, Alan Henderson, Inder S. Anand, Akshay S. Desai, Aldo Maggioni, Felipe A. Martínez, Marc A. Pfeffer, Jean L. Rouleau, Karl Swedberg, Muthiah Vaduganathan, Dirk van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Adel R. Rizkala, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray
Suleman Aktaa, Gorav Batra, John G.F. Cleland, Andrew J.S. Coats, Lars H. Lund, Theresa A. McDonagh, Giuseppe Rosano, Petar Seferović, Peter Vaško, Lars Wallentin, Aldo Maggioni, Barbara Casadei, Chris P Gale
Fozia Ahmed, Paul R. Kalra, John G.F. Cleland, Abdallah Al‐Mohammad, Andrew L. Clark, Victor Chong, Alan G. Japp, Rebecca Lane, Stephen J Leslie, Iain C. Macdougall, Thuraia Nageh, Rajiv Sankaranarayanan, Jolanta Sobolewska, Aaron Wong, Elizabeth Thomson, Mark C. Petrie, Iain Squire, Ian Ford, Philip A. Kalra
Petar Seferović, Mark C. Petrie, Gerasimos Filippatos, Stefan D. Anker, Giuseppe Rosano, Johann Bauersachs, Walter J. Paulus, Michel Komajda, Francesco Cosentino, Rudolf A. de Boer, Dimitrios Farmakis, Wolfram Doehner, Ekaterini Lambrinou, Yu. M. Lopatin, Massimo Piepoli, Michael J. Theodorakis, Henrik Wiggers, John Lekakis, Alexandre Mebazaa, Mamas A. Mamas, Carsten Tschöpe, Arno W. Hoes, Jelena P. Seferović,
Discussion(0)
No comments yet. Be the first to comment.